マイコプラズマ検査の市場規模、シェア、成長分析、製品・サービス別、手法別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

世界のマイコプラズマ検査の市場規模は、2022年に8億2,960万米ドルとなり、2023年には91億1,023万米ドルから、2031年までには19億1,178万米ドルに成長し、予測期間（2024年～2031年）のCAGRは9.72％で成長する見通しです。

マイコプラズマ検査市場は、さまざまな分野でマイコプラズマ汚染を検出・予防するための、信頼性が高く、正確で、効率的なツールやサービスを提供することを目的としています。この市場には、検査、検証、コンサルティングなどのラボサービスと並んで、キット、試薬、機器、ソフトウェアなどのさまざまな製品が含まれます。市場の主要な促進要因としては、バイオ医薬品や細胞ベースの治療に対する需要の高まり、マイコプラズマ汚染のリスクに対する意識の高まり、検査技術の進歩などが挙げられます。厳しい規制要件が、堅牢な検査ソリューションの必要性をさらに高めています。しかし、検査コストの高さ、標準化された検査法の欠如、熟練者の不足といった課題が市場の妨げとなっています。さらに、継続的な技術革新の必要性、偽結果や交差反応性などの問題への対応、進化する需要への適応などが大きな課題となっています。成長の機会としては、新技術の開拓、新たな地域や産業への市場開拓、他の品質管理システムとの検査統合などがあり、デジタル化と自動化の動向を活用して効率と精度を向上させることが挙げられます。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主要な市場の考察

• 主要な成功要因
• 競合の程度
• 主要な投資機会
• 市場のエコシステム
• バリューチェーン分析
• サプライチェーン分析

マイコプラズマ検査市場：製品・サービス別

• 市場概要
• アッセイ、キット、試薬
  • NATアッセイ、キット、試薬
  • 酵素結合免疫吸着アッセイ、キット、試薬
  • 除去キット
  • 染色
  • その他のアッセイ、キット、試薬
• 機器
• サービス

マイコプラズマ検査市場：手法別

• 市場概要
• 核酸検査
• 酵素免疫測定法
• 染色
• その他の手法

マイコプラズマ検査市場：用途別

• 市場概要
• 細胞株試験
• ウイルス検査
• 生産終了時のセルテスト

マイコプラズマ検査市場：エンドユーザー別

• 市場概要
• 製薬・バイオテクノロジー企業
• 医薬品開発業務受託機関
• 学術・研究機関
• 細胞バンク・研究室

マイコプラズマ検査市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Merck KGaA
• Roche Diagnostics（A Division of F. Hoffmann-La Roche Ltd.）
• Charles River Laboratories International, Inc.
• Lonza Group Ltd.
• Thermo Fisher Scientific, Inc.
• Eurofins Scientific Group
• Sartorius Stedim Biotech S.A.
• Agilent Technologies, Inc.
• Meridian Bioscience, Inc.
• American Type Culture Collection
• Bionique Testing Laboratories, Inc.
• InvivoGen
• PromoCell GmbH
• Biological Industries Israel Beit Haemek Ltd.
• Clongen Laboratories, LLC
• Creative Bioarray
• Nelson Laboratories Fairfield, Inc.（A Part of Sotera Health）
• Norgen Biotek Corporation
• Biotools B & M Labs, S.A.
• GenBio（A Part of ExonHit Therapeutics SA）
• GeneCopoeia, Inc.
• Minerva Biolabs GmbH
• Mycoplasma Experience
• Savyon Diagnostics
• ScienceCell Research Laboratories

Global Mycoplasma Testing Market size was valued at USD 829.6 million in 2022 and is poised to grow from USD 9110.23 million in 2023 to USD 1911.78 million by 2031, growing at a CAGR of 9.72% during the forecast period (2024-2031).

The mycoplasma testing market aims to deliver reliable, accurate, and efficient tools and services for detecting and preventing Mycoplasma contamination across various sectors. It includes a range of products such as kits, reagents, instruments, and software, alongside laboratory services like testing, validation, and consulting. Key drivers of the market include the rising demand for biopharmaceuticals and cell-based therapies, heightened awareness of mycoplasma contamination risks, and advancements in testing technologies. Stringent regulatory requirements further propel the need for robust testing solutions. However, challenges such as high testing costs, a lack of standardized methods, and limited skilled personnel hinder the market. Additionally, the need for continuous innovation, addressing issues like false results and cross-reactivity, and adapting to evolving demands pose significant challenges. Opportunities for growth include the development of new technologies, market expansion into new regions and industries, and integrating testing with other quality control systems, while leveraging trends in digitization and automation to improve efficiency and accuracy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycoplasma Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycoplasma Testing Market Segmental Analysis

Global Mycoplasma Testing Market is segmented by Product & Service, Technique, Application, End User, and Region. Based on Product & Service, the market is segmented into Assays, Kits, & Reagents (NAT Assays, Kits, & Reagents; Enzyme-Linked Immunosorbent Assays, Kits, & Reagents, Elimination Kits, Stains, Other Assays, Kits, & Reagents), Instruments, Services. Based on Technique, the market is segmented into Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay, Staining, Other Techniques. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End-Of-Production Cell Testing. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, Cell Banks & Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Mycoplasma Testing Market

As awareness of the risks and consequences associated with Mycoplasma contamination grows, so does the demand for Mycoplasma testing. Contamination can significantly impact experimental results, affecting the reliability of research findings and altering cellular behavior. Additionally, it poses health risks to researchers and patients, further underscoring the need for effective testing solutions to ensure accuracy and safety in various scientific and clinical settings.

Restraints in the Global Mycoplasma Testing Market

The high expense associated with mycoplasma testing products and services can pose a considerable obstacle for many customers, particularly in emerging markets or resource-limited environments. Costs can fluctuate based on the type of test, the complexity of the sample, and the test's sensitivity and specificity. Advanced methods, such as PCR-based assays or high-throughput sequencing, are especially costly and may be out of reach for some customers, further limiting accessibility.

Market Trends of the Global Mycoplasma Testing Market

The integration of Mycoplasma testing with other quality control and assurance systems, such as microbial identification, endotoxin testing, and bioburden testing, is increasingly common in the market. This trend enables customers to consolidate their testing processes, leading to more efficient workflows. By combining these tests, customers can achieve faster turnaround times and reduce overall testing costs, enhancing both operational efficiency and cost-effectiveness.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis

Mycoplasma Testing Market, By Product & Service

• Market Overview
• Assays, Kits, & Reagents
  • NAT Assays, Kits, & Reagents
  • Enzyme-Linked Immunosorbent Assays, Kits, & Reagents
  • Elimination Kits
  • Stains
  • Other Assays, Kits, & Reagents
• Instruments
• Services

Mycoplasma Testing Market, By Technique

• Market Overview
• Nucleic Acid Testing
• Enzyme-Linked Immunosorbent Assay
• Staining
• Other Techniques

Mycoplasma Testing Market, By Application

• Market Overview
• Cell Line Testing
• Virus Testing
• End-Of-Production Cell Testing

Mycoplasma Testing Market, By End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes
• Cell Banks & Laboratories

Mycoplasma Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius Stedim Biotech S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Type Culture Collection
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionique Testing Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InvivoGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological Industries Israel Beit Haemek Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clongen Laboratories, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nelson Laboratories Fairfield, Inc. (A Part of Sotera Health)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotools B & M Labs, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenBio (A Part of ExonHit Therapeutics SA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCopoeia, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minerva Biolabs GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mycoplasma Experience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Savyon Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienceCell Research Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments